Katarzyna Fleischer‐Stępniewska
Wroclaw Medical University(PL)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Systemic Lupus Erythematosus Research, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment
Most-Cited Works
- → Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial(2015)257 cited
- → Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study(2016)99 cited
- → O58 RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/R + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION(2014)33 cited
- → Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free Therapy(2021)29 cited
- → Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real‐world experience study(2018)26 cited
- → Evaluation of brain volume alterations in HCV-infected patients after interferon-free therapy: A pilot study(2019)18 cited
- → Visual and brainstem auditory evoked potentials in HCV-infected patients before and after interferon-free therapy — A pilot study(2019)14 cited
- → Interferon‐free therapy as the cause of white matter tracts and cerebral perfusion recovery in patients with chronic hepatitis C(2019)10 cited
- → Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals(2019)5 cited
- → Genetic diagnosis of seronegative (HIV−) partner of female patient with AIDS in the context of HIV transmission(2016)4 cited